Anavex Life Sciences Corp (AVXL)

[Amatuer17]

You say -" But both physicians and patients will prefer Anavex 2-73, because of its enduring efficacy."

On what basis - just 25 patients trial?
The results are inconclusive at best.

Their P3 top line reading will come out by Oct and looking at speed in AVXL - they won't even start the Alz P2 trial by that time. So 2-73 is literally years away from giving reading on decent size study. By that time RV-101 will become new SOC if approved.

So first things first - get the trial started then talk about efficacy.